No Data
Stocks hitting the upper or lower price limit in the afternoon session.
■Top gainers: Fuji Kokka E&C <1775>, Sapeet <269A>, SBI Saudi Arabia Stock Listed Investment Trust <3779>, Jay Escom Holdings <4598>, Delta-Fly Pharma <6391>, Kaji Tech <7901>, Matsumoto <7971>, Toli <8732>, Money Partners Group ■Top losers: RSC <4664>, Emplus ※Includes temporary upper and lower limits (indicative values).
Stocks that moved the previous day part 2: M&A Soken, Housecom, ROXX, etc.
Stock name <Code> 30-day closing price ⇒ Day-on-day comparison M&A Research <9552> 2408 -333M & A Negative view on revising the number of M&A advisors. Hino Motors <7205> 406.1 -62.5 Negative view on significantly forecasting a large final deficit due to certification related losses. Goodcom Asset <3475> 829 -79 The impact of rights offerings on high yield stocks is increasing. DAIDO Special Steel <5471> 1211 -116.5 Downward revision of full-year financial estimates. Medley <448
T&S G, LPF and others
<4055> Tian De Es G established a subsidiary <4598> DELTA-P 8th round of subscription rights (with exercise price adjustment clause) with a large number of exercises, 0.25 million shares to be issued from the 30th <7091> LPF established a subsidiary.
Active and newly listed stocks during the morning session.
*ElemaTek<2715> 2105 K- Toyota Tsusho plans to conduct a TOB at 2400 yen. *Comtuar<3844> 2280 K- There are reports circulating about considering going private, among other things. *Yamazaki Baking<2212> 3045 +363.5 Announced implementation of product price increases starting next year. *Disco<6146> 45860 +5110 Also shifting attention anew towards AI semiconductor related fields. *Shikoku Electrical Utilities<9507> 1368 +143.5 According to financial estimates, a significant improvement in performance is expected.
Cover, Truce OP, and other emerging markets press releases.
Persol Career, which handles ROXX personnel introduction services and other services, has signed dealer contracts. Miratap, code 3187, downwardly revises its forecast, with the previous term's operating profit outlook of 0.839 billion yen down from 1.3 billion yen. Ingate, which handles Cloud Works personnel introduction, recruitment support, and career counseling services, has acquired shares and become a subsidiary. Delta-P, code 4598, will exercise a large number of subscription rights in the 8th round (with revised exercise price clause), with the number of shares to be issued from the 29th to 0.3 million shares. Covering, code 5253.
Emerging markets stocks digest: Fulta continues to rise significantly, sea U sea hits the daily limit.
<4598> DELTA-P 533 +47 surged significantly. After the trading on the 28th, the progress of the phase 1/2 clinical trial of DFP-10917 and VEN was announced, which is considered a positive development. DFP-10917, when given as a low-dose continuous infusion, is believed to be highly safe, stops cancer cells in the G2/M phase, and induces apoptosis (programmed cell death). Therefore, a strong synergistic effect can be expected when combined with VEN (a BCL-2 inhibitor). Currently, a phase 1 clinical trial is underway.
No Data
No Data